Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age
about
Performance of rotavirus vaccines in developed and developing countriesPrevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines.Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study.Rotavirus vaccines: an overview.Ionizing air affects influenza virus infectivity and prevents airborne-transmissionMolecular epidemiology and clinical manifestations of viral gastroenteritis in hospitalized pediatric patients in Northern Taiwan.Complicated norovirus infection and assessment of severity by a modified Vesikari disease score system in hospitalized children.A Bayesian approach to estimating causal vaccine effects on binary post-infection outcomesRotavirus infection: a perspective on epidemiology, genomic diversity and vaccine strategies.Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers.Why does the world need another rotavirus vaccine?Causal Vaccine Effects on Binary Postinfection Outcomes.Intestinal microbiome in children with severe and complicated acute viral gastroenteritis.The Density Code for the Development of a Vaccine?Protection of agammaglobulinemic piglets from porcine rotavirus infection by antibody against simian rotavirus SA-11.
P2860
Q24600612-B4A8A71A-BF0D-4FBA-B01E-A1E72DA9BBD3Q34064371-1EA79A1A-4B01-4F28-935A-7347A0D016BAQ34146235-141F0859-7B08-4AD7-9952-0D846942CFADQ35371774-D6E9F680-815C-40DB-BAAF-058E6887AEC7Q35769162-8E06721A-3B0B-4B48-8D8E-51DCA25B1A0AQ35913909-44D01C9C-B3F4-4F08-8EFC-5BD390E295FDQ36157186-6DC23BD7-5528-410C-8465-34FD4597C135Q36469702-7452A338-6CF5-4A65-B2C4-D7F3415A5A59Q36550022-D99B3F5E-8746-476A-9512-1DCA15A96F15Q36656398-CD68CA6B-D840-472A-949D-4ED2D6ED85C9Q36822928-F226D3B3-085E-43E4-B958-A5D27B43B993Q37016771-BAEC715C-8131-457D-A313-17312C2FFB25Q37748140-72CF24BD-367C-4BB0-A9FB-7FE3F0F4D9F7Q38959835-76B7EAC1-70A5-455A-974C-4F147BD40C3AQ40212910-698746CC-9B3F-4955-908E-5D6E90B9D66A
P2860
Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 1990
@uk
name
Rhesus Rotavirus candidate vac ...... between 2 and 5 months of age
@en
Rhesus Rotavirus candidate vac ...... between 2 and 5 months of age
@nl
type
label
Rhesus Rotavirus candidate vac ...... between 2 and 5 months of age
@en
Rhesus Rotavirus candidate vac ...... between 2 and 5 months of age
@nl
prefLabel
Rhesus Rotavirus candidate vac ...... between 2 and 5 months of age
@en
Rhesus Rotavirus candidate vac ...... between 2 and 5 months of age
@nl
P2093
P1476
Rhesus Rotavirus candidate vac ...... between 2 and 5 months of age
@en
P2093
A Z Kapikian
G M Beards
T Rautanen
T Vesikari
P407
P577
1990-03-01T00:00:00Z